Excerpt: In order to effectively and responsibly address the question of clarifying or enhancing FDA’s authority over compounding pharmacies, the committee must identify what happened at the New England Compounding Center (NECC), and why FDA did not use its authority to take enforcement action against NECC until October 2012, after the meningitis outbreak.
Chairman:
Tim Murphy (PA-18)
Jurisdiction:
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.
Members
Republicans
Chairman: Tim Murphy (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Steve Scalise (LA)
Gregg Harper (MS)
Pete Olson (TX)
Cory Gardner (CO)
Morgan Griffith (VA)
Bill Johnson (OH)
Billy Long (MO)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)
Democrats
Ranking Member: Diana DeGette (CO)
Bruce Braley (IA)
Ben Ray Lujan (NM)
Edward J. Markey (MA)
Jan Schakowsky (IL)
G.K. Butterfield (NC)
Kathy Castor (FL)
Peter Welch (VT)
Paul Tonko (NY)
Gene Green (TX)
John D. Dingell (MI) (non-voting)
Henry A. Waxman (CA)
November 19, 2012 |
Letter
November 15, 2012 |
Letter
Excerpt: We write to express our strong opposition to certain provisions relating to the Department of Energy’s nuclear defense and related programs in the House-passed national defense authorization bill.
November 15, 2012 |
Blog Post
WASHINGTON, DC – The Oversight and Investigations Subcommittee yesterday held a hearing to discuss the deadly meningitis outbreak, which has resulted in 32 deaths and sickened hundreds across the country. Three folks from Marion County, Florida have died, and one victim lived right up the street from me.
November 14, 2012 |
Hearing
November 13, 2012 |
Letter
Excerpt: As United Health Group’s insurance plans will likely try to be named as Qualified Health Plans in the health exchanges, including the federal exchange, please describe the processes and procedures that will be in place to guarantee that United Health Group will not receive preferential treatment by its subsidiary QSSI.
November 13, 2012 |
Letter
To read the letter to the Centers for Disease Control and Prevention, click here.